To further understand the role of SBNO2 in the CNS and, in particular, in IL-6-mediated neurological disease, we generated a new mouse model with disruption of Sbno2 and crossed these mice with the GFAP-IL6 transgenic mice. Here, SBNO2 is linked to nervous system disorder.